NCT06542458

Brief Summary

Overall, this study's primary aim is to establish a prospective, longitudinal, observational cohort study of older adults at risk for dementia from under-resourced/underrepresented communities. More specifically, older adults diagnosed with subjective cognitive decline (SCD) or Mild Cognitive Impairment (MCI) during clinical care offered via the Tele-Cog clinic would be recruited for more comprehensive data collection to characterize the clinical presentation and course of illness over multiple timepoints spread out longitudinally.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
62mo left

Started Dec 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2024

Completed
2.3 years until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2032

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2032

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

5.1 years

First QC Date

August 5, 2024

Last Update Submit

February 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI) at risk for dementia from under-resourced/underrepresented communities that we longitudinally collect clinical data, neuropsychology, neuroimaging, and biofluids

    This study is a longitudinal collection of clinical data, neuroimaging, neuropsychological assessments, and biofluids to establish a cohort of older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI) at risk for dementia from under-resourced/underrepresented communities from which hypotheses can be generated. Analysis will also include comparing the subject's longitudinal change over time data. Data will be analyzed with one way and repeated measures (ANOVAs) that will control for important covariates. All imaging data will be analyzed using qualitative visual interpretation and quantitative region of interest approach.

    5 years

Study Arms (1)

Study Population

Adults ages 50 years and older who are fluent in English and are diagnosed with subjective cognitive concerns (SCD) or objective cognitive decline with mostly intact functioning (MCI diagnosis) as part of clinical work up

Behavioral: AssessmentsOther: Neuroimaging volumetric measuresOther: Biofluid samples

Interventions

AssessmentsBEHAVIORAL

Participants will undergo a standard battery of neuropsychological measures, behavioral questionnaire, and functional assessment to monitor cognition and function over time. Clinical data obtained as part of standard of care will be collected from the medical record

Study Population

Neuroimaging volumetric measures will be obtained from already conducted standard of care neuroimaging.

Study Population

Biofluid sampling data will be obtained through another protocol. All participants will be required to sign that consent to participate in this trial.

Study Population

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals will be recruited from the Tele-Cog clinic at The Ohio State University Wexner Medical Center.

You may qualify if:

  • Adults ages 50 years and older
  • Diagnosed with subjective cognitive concerns (SCD) or objective cognitive decline with mostly intact functioning (MCI diagnosis) as part of clinical work up
  • Fluent in English
  • Able to provide voluntary informed consent
  • Willing and able to undergo all study procedures
  • Able to delegate, if possible, a study partner to contribute information regarding daily activities and cognition

You may not qualify if:

  • Diagnosis of dementia at baseline.
  • Inability to give informed consent.
  • High risk of adverse emotional or behavioral reaction based on investigator's clinical evaluation (e.g., evidence of serious personality disorder, antisocial behavior, serious current stressors, lack of meaningful social support).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Jessica Pommy, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor-Clinical

Study Record Dates

First Submitted

August 5, 2024

First Posted

August 7, 2024

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

January 1, 2032

Study Completion (Estimated)

January 1, 2032

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations